Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PTEN deficiency promotes pathological vascular remodeling of human coronary arteries.
Moulton KS, Li M, Strand K, Burgett S, McClatchey P, Tucker R, Furgeson SB, Lu S, Kirkpatrick B, Cleveland JC, Nemenoff RA, Ambardekar AV, Weiser-Evans MC. Moulton KS, et al. JCI Insight. 2018 Feb 22;3(4):e97228. doi: 10.1172/jci.insight.97228. eCollection 2018 Feb 22. JCI Insight. 2018. PMID: 29467331 Free PMC article.
PTEN (Phosphatase and Tensin Homolog) Protects Against Ang II (Angiotensin II)-Induced Pathological Vascular Fibrosis and Remodeling-Brief Report.
Lu S, Strand KA, Mutryn MF, Tucker RM, Jolly AJ, Furgeson SB, Moulton KS, Nemenoff RA, Weiser-Evans MCM. Lu S, et al. Among authors: moulton ks. Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):394-403. doi: 10.1161/ATVBAHA.119.313757. Epub 2019 Dec 19. Arterioscler Thromb Vasc Biol. 2020. PMID: 31852223 Free PMC article.
High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog): Central Role for PTEN in 5-Azacytidine Protection Against Pathological Vascular Remodeling.
Strand KA, Lu S, Mutryn MF, Li L, Zhou Q, Enyart BT, Jolly AJ, Dubner AM, Moulton KS, Nemenoff RA, Koch KA, LaBarbera DV, Weiser-Evans MCM. Strand KA, et al. Among authors: moulton ks. Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1854-1869. doi: 10.1161/ATVBAHA.120.314458. Epub 2020 Jun 25. Arterioscler Thromb Vasc Biol. 2020. PMID: 32580634 Free PMC article.
Reply: Aortic Valve Remodeling in CF-LVAD: Beyond the Arterial Wall.
Ambardekar AV, Stratton MS, Weiser-Evans MCM, Moulton KS, McKinsey TA. Ambardekar AV, et al. Among authors: moulton ks. J Am Coll Cardiol. 2022 Mar 29;79(12):e223. doi: 10.1016/j.jacc.2022.01.027. J Am Coll Cardiol. 2022. PMID: 35331421 Free article. No abstract available.
Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research-Brief Report.
Dubner AM, Lu S, Jolly AJ, Noble T, Hinthorn T, Nemenoff RA, Moulton KS, Majesky MW, Weiser-Evans MCM. Dubner AM, et al. Among authors: moulton ks. Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2223-2230. doi: 10.1161/ATVBAHA.123.319922. Epub 2023 Sep 14. Arterioscler Thromb Vasc Biol. 2023. PMID: 37706321
37 results